Abstract
Eleven monoterpenoid indole alkaloids, including three new ones, tabercrassines A–C (1–3), were isolated from the seeds of Tabernaemontana crassa. Tabercrassine A (1) is an ibogan–ibogan-type bisindole alkaloid which is formed by the polymerization of two classic ibogan-type monomers through a C3 unit aliphatic chain. Their structures were established by extensive analysis of HRESIMS, NMR, and ECD spectra. Cellular assays showed that alkaloids 1–3 all reduce Aβ42 production and inhibit phospho-tau (Thr217), a new biomarker of Alzheimer’s disease [AD] associated with BACE1-, NCSTN-, GSK3β-, and CDK5-mediated pathways, suggesting these alkaloids’ potential against AD.
Funder
National Key R & D Program of China
NSFC
Yunnan Revitalization Talents Support Plan-Young Talent Project
the Yunnan Science and Technology Plan Project
the Youth Innovation Promotion Association of CAS
the CAS “Light of West China” Program
the Open Project from Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference62 articles.
1. GBD 2015 Neurological Disorders Collaborator Group (2017). Global, regional, and national burden of neurological disorders during 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol., 16, 877–897.
2. Alzheimer’s Association (2015). 2015 Alzheimer’s disease facts and figures. Alzheimers Dement., 11, 332–384.
3. Alzheimer’s disease;Querfurth;N. Engl. J. Med.,2010
4. Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the national institute on aging-Alzheimer’s association research framework;Jack;JAMA Neurol.,2019
5. Alzheimer’s disease;Scheltens;Lancet,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献